Effects of Inhaled Corticosteroids on Mortality and Hospitalisation in Elderly Asthma and Chronic Obstructive Pulmonary Disease PatientsAppraising the Evidence

被引：0
|
作者：
Jordana K. Schmier
Michael T. Halpern
Mechelle L. Jones
机构：
[1] Exponent Inc.,
来源：
Drugs & Aging | 2005年 / 22卷
关键词：
Chronic Obstructive Pulmonary Disease; Chronic Obstructive Pulmonary Disease Patient; Fluticasone Propionate; Salmeterol; Chronic Obstructive Pulmonary Disease Exacerbation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Asthma and chronic obstructive pulmonary disease (COPD) are common conditions that have substantial effects on daily functioning and medical resource utilisation. In elderly populations, the use of inhaled corticosteroids (ICS) as a mainstay of treatment in asthma has long been accepted whereas the appropriateness and extent of use of ICS in COPD is not as clear. This paper reviews data associated with ICS treatment in the elderly, specifically characteristics of ICS users, rates of adherence, hospitalisation and mortality associated with ICS treatment.
引用
收藏
页码：717 / 729
页数：12
相关论文
共 50 条
  • [31] Influence of Inhaled Corticosteroids on Bronchial Inflammation and Pulmonary Function in Chronic Obstructive Pulmonary Disease with Moderate Obstruction
    Toczyska, Iza
    Zwolinska, Ewa
    Chcialowski, Andrzej
    CLINICAL INVESTIGATION, 2018, 1047 : 41 - 52
  • [32] Long term effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis
    van Grunsven, PM
    van Schayck, CP
    Derenne, JP
    Kerstjens, HAM
    Renkema, TEJ
    Postma, DS
    Similowski, T
    Akkermans, RP
    Pasker-de Jong, PCM
    Dekhuijzen, PNR
    van Herwaarden, CLA
    van Weel, C
    THORAX, 1999, 54 (01) : 7 - 14
  • [33] Effects of inhaled corticosteroids /long-acting agonists in a single inhaler versus inhaled corticosteroids alone on all-cause mortality, pneumonia, and fracture in chronic obstructive pulmonary disease: A nationwide cohort study 2002-2013
    Cho, Kyoung Hee
    Kim, Young Sam
    Linton, John A.
    Nam, Chung Mo
    Choi, Young
    Park, Eun-Cheol
    RESPIRATORY MEDICINE, 2017, 130 : 75 - 84
  • [34] Comparative Efficacies of Inhaled Corticosteroids and Systemic Corticosteroids in Treatment of Chronic Obstructive Pulmonary Disease Exacerbations: A Systematic Review and Meta-Analysis
    Zhai, Yuhan
    Zhang, He
    Sun, Tingli
    Ye, Maosheng
    Liu, Hongbo
    Zheng, Rui
    JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2017, 30 (05) : 289 - 298
  • [35] Inhaled corticosteroids in chronic obstructive pulmonary disease: is there a long-term benefit?
    Highland, KB
    CURRENT OPINION IN PULMONARY MEDICINE, 2004, 10 (02) : 113 - 119
  • [36] Risk of pneumonia with inhaled corticosteroids for stable chronic obstructive pulmonary disease patients
    Ruiz Garcia, Vicente
    Compte Torrero, Luis
    MEDICINA CLINICA, 2011, 137 (07): : 302 - 304
  • [37] Inhaled corticosteroids and fractures in chronic obstructive pulmonary disease: current understanding and recommendations
    Moon, Ji-Yong
    Sin, Don D.
    CURRENT OPINION IN PULMONARY MEDICINE, 2019, 25 (02) : 165 - 172
  • [38] Inhaled corticosteroids and FEV1 decline in chronic obstructive pulmonary disease: a systematic review
    Whittaker, Hannah R.
    Jarvis, Debbie
    Sheikh, Mohamed R.
    Kiddle, Steven J.
    Quint, Jennifer K.
    RESPIRATORY RESEARCH, 2019, 20 (01)
  • [39] A re-evaluation of the role if inhaled corticosteroids in the management of patients with chronic obstructive pulmonary disease
    D'Urzo, Anthony
    Donohue, James F.
    Kardos, Peter
    Miravitlles, Marc
    Price, David
    EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (12) : 1845 - 1860
  • [40] Initiating Low-Value Inhaled Corticosteroids in an Inception Cohort with Chronic Obstructive Pulmonary Disease
    Spece, Laura J.
    Donovan, Lucas M.
    Griffith, Matthew F.
    Keller, Thomas
    Feemster, Laura C.
    Smith, Nicholas L.
    Au, David H.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2020, 17 (05) : 589 - 595
12345